Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neighbourly Pharmacy Inc T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Comment by Kanatainvestoron Sep 07, 2023 2:44pm
84 Views
Post# 35624654

RE:RE:RE:This is not a $14/$15 stock

RE:RE:RE:This is not a $14/$15 stockOne thing to keep in mind is that in 2021, when the year NBLY came public, NBLY generated 34.5m in EBITDA (up from 21M in 2020 the last year as a private company. Today, as of the last fiscal year the company generated $74m in EBITDA meanwhile the share count expanded from 33m to 44m during this period, which means the EBITDA per share expanded from $1.05 to $1.68. As such, the IPO price is increasingly irrelevant as a reference point, the stock here is worth much more than in 2021, and this is even if we were to adjust for higher debt and higher interest rates.  Based on my model, NBLY is worth $20 to $21 at minimum today.

PS. the financial number cited in the psot stem from Dow Jones Factiva.


<< Previous
Bullboard Posts
Next >>